1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
  1. Launch

Neurotec

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2006

Location

Barcelona Spain

Primary Industry

Healthcare

About

Neurotec is a Spain-based company that operates as a developer of new treatments for acute and chronic Central Nervous System (CNS) diseases.
Current Investors
Inveready Asset Management, Caja Navarra

Request a demo to show more

Primary Industry
Healthcare
Sub Industries
Epidemiology
Website
www.neurotec-pharma.com
Total Amount Raised
Subscriber access only

Financials

Fiscal Year Ended
Revenue (USD)
% Revenue Growth (YoY)
Operating Income (USD)
Operating Margin
EBITDA (USD)
% EBITDA Margin
NET Income (USD)
% Net Margin
31 Dec 2009
243,550
-
136,297
56%
145,327
59.7%
28,124
11.5%
31 Dec 2010
248,032
1.8%
(38,469)
(15.5%)
(27,598)
(11.1%)
(32,493)
(13.1%)
31 Dec 2011
31 Dec 2012
31 Dec 2013

Unlock the recent years of financials and more for Neurotec.

Request a demo to see more.

Employee Data

Employee Graph

Want to see the Employee Count?

Request a demo for full access to this profile.

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.